Galantas Gold Announces Completion of Trial Stoping Program at Omagh Gold Project, Northern Ireland Read more
CALQUENCE ® (acalabrutinib) plus chemoimmunotherapy reduced the risk of disease progression or death by 27% vs. standard of care in patients with untreated mantle cell lymphoma in ECHO Phase III trial Read more
JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89) Read more
Massive Bitcoin Volatility, Ripple (XRP) Trial, and CZ’s Sentencing: This Week’s Crypto Recap Read more